Table 5

Incidence of clinical worsening in patients with PAH-CHD in Pulmonary Arterial hyperTENsion sGC-stimulator Trial-2

Clinical worsening event, n (%)*Total (n=33)
Patients with clinical worsening8 (24)
 Hospitalisation due to PH4 (12)
 Start of new PH treatment7 (21)
 Decrease in 6MWD due to PH2 (6)
 Death4 (12)
  • *One patient can experience more than one event.

  • 6MWD, 6-min walking distance; CHD, congenital heart disease; PAH, pulmonary atrial hypertension; PH, pulmonary hypertension.